Introducing PIONEER : a project to harness big data in prostate cancer research
(2020) In Nature Reviews Urology 17(6). p.351-361- Abstract
Prostate Cancer Diagnosis and Treatment Enhancement Through the Power of Big Data in Europe (PIONEER) is a European network of excellence for big data in prostate cancer, consisting of 32 private and public stakeholders from 9 countries across Europe. Launched by the Innovative Medicines Initiative 2 and part of the Big Data for Better Outcomes Programme (BD4BO), the overarching goal of PIONEER is to provide high-quality evidence on prostate cancer management by unlocking the potential of big data. The project has identified critical evidence gaps in prostate cancer care, via a detailed prioritization exercise including all key stakeholders. By standardizing and integrating existing high-quality and multidisciplinary data sources from... (More)
Prostate Cancer Diagnosis and Treatment Enhancement Through the Power of Big Data in Europe (PIONEER) is a European network of excellence for big data in prostate cancer, consisting of 32 private and public stakeholders from 9 countries across Europe. Launched by the Innovative Medicines Initiative 2 and part of the Big Data for Better Outcomes Programme (BD4BO), the overarching goal of PIONEER is to provide high-quality evidence on prostate cancer management by unlocking the potential of big data. The project has identified critical evidence gaps in prostate cancer care, via a detailed prioritization exercise including all key stakeholders. By standardizing and integrating existing high-quality and multidisciplinary data sources from patients with prostate cancer across different stages of the disease, the resulting big data will be assembled into a single innovative data platform for research. Based on a unique set of methodologies, PIONEER aims to advance the field of prostate cancer care with a particular focus on improving prostate-cancer-related outcomes, health system efficiency by streamlining patient management, and the quality of health and social care delivered to all men with prostate cancer and their families worldwide.
(Less)
- author
- author collaboration
- organization
- publishing date
- 2020
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Nature Reviews Urology
- volume
- 17
- issue
- 6
- pages
- 11 pages
- publisher
- Nature Publishing Group
- external identifiers
-
- scopus:85085488421
- pmid:32461687
- ISSN
- 1759-4812
- DOI
- 10.1038/s41585-020-0324-x
- language
- English
- LU publication?
- yes
- id
- 4e0d6d2f-5e4c-4510-ac3b-fe1fc3732985
- date added to LUP
- 2020-06-23 08:32:25
- date last changed
- 2024-09-20 00:18:46
@article{4e0d6d2f-5e4c-4510-ac3b-fe1fc3732985, abstract = {{<p>Prostate Cancer Diagnosis and Treatment Enhancement Through the Power of Big Data in Europe (PIONEER) is a European network of excellence for big data in prostate cancer, consisting of 32 private and public stakeholders from 9 countries across Europe. Launched by the Innovative Medicines Initiative 2 and part of the Big Data for Better Outcomes Programme (BD4BO), the overarching goal of PIONEER is to provide high-quality evidence on prostate cancer management by unlocking the potential of big data. The project has identified critical evidence gaps in prostate cancer care, via a detailed prioritization exercise including all key stakeholders. By standardizing and integrating existing high-quality and multidisciplinary data sources from patients with prostate cancer across different stages of the disease, the resulting big data will be assembled into a single innovative data platform for research. Based on a unique set of methodologies, PIONEER aims to advance the field of prostate cancer care with a particular focus on improving prostate-cancer-related outcomes, health system efficiency by streamlining patient management, and the quality of health and social care delivered to all men with prostate cancer and their families worldwide.</p>}}, author = {{Omar, Muhammad Imran and Roobol, Monique J. and Ribal, Maria J. and Abbott, Thomas and Agapow, Paul Michael and Araujo, Sonia and Asiimwe, Alex and Auffray, Charles and Balaur, Irina and Beyer, Katharina and Bernini, Chiara and Bjartell, Anders and Briganti, Alberto and Butler-Ransohoff, John Edward and Campi, Riccardo and Cavelaars, Marinel and De Meulder, Bertrand and Devecseri, Zsuzsanna and Voss, Marc Dietrich and Dimitropoulos, Konstantinos and Evans-Axelsson, Susan and Franks, Billy and Fullwood, Louise and Horgan, Denis and Smith, Emma Jane and Kiran, Amit and Kivinummi, Kati and Lambrecht, Mark and Lancet, Doron and Lindgren, Peter and MacLennan, Sara and MacLennan, Steven and Nogueira, Maria Manuela and Moen, Fredrik and Moinat, Maxim and Papineni, Kishore and Reich, Christian and Reiche, Kristin and Rogiers, Stijn and Sartini, Claudio and van Bochove, Kees and van Diggelen, Femke and Van Hemelrijck, Mieke and Van Poppel, Hein and Zong, Jihong and N’Dow, James}}, issn = {{1759-4812}}, language = {{eng}}, number = {{6}}, pages = {{351--361}}, publisher = {{Nature Publishing Group}}, series = {{Nature Reviews Urology}}, title = {{Introducing PIONEER : a project to harness big data in prostate cancer research}}, url = {{http://dx.doi.org/10.1038/s41585-020-0324-x}}, doi = {{10.1038/s41585-020-0324-x}}, volume = {{17}}, year = {{2020}}, }